data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Xencor
(NASDAQ:XNCR)
27.12
0.54[2.03%]
At close: Jun 24
27.12
00
After Hours: 4:02PM EDT
Day High/Low25.34 - 27.32
52 Week High/Low19.36 - 43.61
Open / Close26.85 / 27.12
Float / Outstanding35.8M / 59.5M
Vol / Avg.2.1M / 378.4K
Mkt Cap1.6B
P/E15.07
50d Avg. Price23.87
Div / Yield-
Payout Ratio-
EPS0.4
Total Float35.8M

Xencor (NASDAQ:XNCR), Quotes and News Summary

Xencor (NASDAQ: XNCR)

Day High/Low25.34 - 27.32
52 Week High/Low19.36 - 43.61
Open / Close26.85 / 27.12
Float / Outstanding35.8M / 59.5M
Vol / Avg.2.1M / 378.4K
Mkt Cap1.6B
P/E15.07
50d Avg. Price23.87
Div / Yield-
Payout Ratio-
EPS0.4
Total Float35.8M
Benzinga - May 26, 2022, 5:14PM
Benzinga - May 23, 2022, 8:26AM
Benzinga - May 5, 2022, 4:39PM
Benzinga - Apr 8, 2022, 1:03PM
Benzinga - Mar 8, 2022, 4:33PM
Benzinga - Feb 24, 2022, 6:22AM
Benzinga - Feb 23, 2022, 4:23PM
Benzinga - Feb 11, 2022, 8:23AM
Benzinga - Dec 15, 2021, 6:39AM
Benzinga - Dec 12, 2021, 9:23AM
Benzinga - Nov 24, 2021, 1:23PM
Benzinga - Nov 22, 2021, 7:06AM
Benzinga - Nov 22, 2021, 5:00AM
Benzinga - Nov 9, 2021, 1:14PM
Benzinga - Nov 8, 2021, 4:05PM
load more
Sector: Health Care.Industry: Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.6000.390 0.9900
REV25.730M85.495M59.765M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Xencor Questions & Answers

Q
How do I buy Xencor (XNCR) stock?
A

You can purchase shares of Xencor (NASDAQ: XNCR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Xencor's (XNCR) competitors?
Q
What is the target price for Xencor (XNCR) stock?
A

The latest price target for Xencor (NASDAQ: XNCR) was reported by Piper Sandler on Monday, May 23, 2022. The analyst firm set a price target for 42.00 expecting XNCR to rise to within 12 months (a possible 54.87% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Xencor (XNCR)?
A

The stock price for Xencor (NASDAQ: XNCR) is $27.12 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Xencor (XNCR) pay a dividend?
A

There are no upcoming dividends for Xencor.

Q
When is Xencor (NASDAQ:XNCR) reporting earnings?
A

Xencor’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Xencor (XNCR) going to split?
A

There is no upcoming split for Xencor.

Q
What sector and industry does Xencor (XNCR) operate in?
A

Xencor is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.